MCID: HRP004
MIFTS: 56

Herpes Zoster malady

Categories: Skin diseases, Infectious diseases

Aliases & Classifications for Herpes Zoster

Aliases & Descriptions for Herpes Zoster:

Name: Herpes Zoster 12 51 52 3 42 14
Shingles 12 51 41 3 14
Herpes Zoster Disease 69
Herpes Zona 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8536
ICD10 33 B02 B02.9
ICD9CM 35 053
MeSH 42 D006562
NCIt 47 C71079
UMLS 69 C0019360

Summaries for Herpes Zoster

MedlinePlus : 41 shingles is a disease caused by the varicella-zoster virus - the same virus that causes chickenpox. after you have chickenpox, the virus stays in your body. it may not cause problems for many years. as you get older, the virus may reappear as shingles. although it is most common in people over age 50, anyone who has had chickenpox is at risk. you can't catch shingles from someone who has it. however, if you have a shingles rash, you can pass the virus to someone who has never had chickenpox. this would usually be a child, who could get chickenpox instead of shingles. the virus spreads through direct contact with the rash, and cannot spread through the air. early signs of shingles include burning or shooting pain and tingling or itching, usually on one side of the body or face. the pain can be mild to severe. rashes or blisters appear anywhere from one to 14 days later. if shingles appears on your face, it may affect your vision or hearing. the pain of shingles may last for weeks, months, or even years after the blisters have healed. there is no cure for shingles. early treatment with medicines that fight the virus may help. these medicines may also help prevent lingering pain. a vaccine may prevent shingles or lessen its effects. the vaccine is recommended for people 60 or over. in some cases doctors may give it to people ages 50 to 59. nih: national institute of allergy and infectious diseases

MalaCards based summary : Herpes Zoster, also known as shingles, is related to facial paralysis and pulmonary tuberculosis, and has symptoms including rash which is followed by blisters, headache and fever. An important gene associated with Herpes Zoster is DPYD (Dihydropyrimidine Dehydrogenase), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Immune response NFAT in immune response. The drugs Capsaicin and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include skin, eye and t cells.

Disease Ontology : 12 A viral infectious disease that results_in infection located in nerve fiber, has material basis in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The virus is transmitted_by direct contact with the rash, which can develop into chickenpox in newly-infected individuals. The infection has symptom rash which is followed by blisters, has symptom headache, has symptom fever, has symptom malaise, has symptom itching, has symptom burning pain, and has symptom paresthesia.

CDC : 3 Almost 1 out of every 3 people in the United States will develop shingles, also known as zoster or herpes zoster, in their lifetime. There are an estimated 1 million cases of shingles each year in this country. Anyone who has recovered from chickenpox may develop shingles; even children can get shingles. However the risk of shingles increases as you get older. About half of all cases occur in men and women 60 years old or older...

NINDS : 51 Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain (which can be severe), or sometimes numbness or itch,generally on one side of the body. After several days or a week, a rash of fluid-filled blisters, similar to chickenpox, appears in one area on one side of the body. Shingles pain can be mild or intense.  Some people have mostly itching; some feel pain from the gentlest touch or breeze.  The most common location for shingles is a band, called a dermatome, spanning one side of the trunk around the waistline. Anyone who has had chickenpox is at risk for shingles.  Scientists think that some of the virus particles from the original exposure to the varicella-zoster virus,leave the skin blisters and move into the nervous system.  When the varicella-zoster virus reactivates, the virus moves back down the long nerve fibers that extend from the sensory cell bodies to the skin.  The viruses multiply, the tell-tale rash erupts, and the person now has shingles.

Wikipedia : 71 Shingles, also known as herpes zoster, is a viral disease characterized by a painful skin rash with... more...

Related Diseases for Herpes Zoster

Diseases related to Herpes Zoster via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 336)
id Related Disease Score Top Affiliating Genes
1 facial paralysis 29.5 CD40LG IL10
2 pulmonary tuberculosis 29.4 CD40LG IFNG IL10
3 anaplastic large cell lymphoma 29.3 IFNG IL2 TMPO
4 chorioretinitis 29.3 CD40LG FCGR3A IFNG IL10
5 hepatitis 29.3 HLA-A IFNG IL10 IL2
6 myiasis 29.3 CD40LG IFNG IL10 IL2
7 tuberculosis 29.2 CD40LG CD8A IL10 IL2
8 acute dacryoadenitis 29.1 CD40LG CD8A IL2
9 geniculate herpes zoster 12.5
10 herpes zoster ophthalmicus 12.5
11 postherpetic neuralgia 11.6
12 asymptomatic neurosyphilis 10.3 IFNG IL10
13 autoimmune progesterone dermatitis 10.2 IFNG TRPV1
14 maturity-onset diabetes of the young 10.2 CD40LG IL10
15 renal agenesis meningomyelocele mullerian defect 10.2 IFNA2 IL2
16 caplan's syndrome 10.2 IFNG IL2
17 autosomal dominant deafness-onychodystrophy syndrome 10.2 IFNG IL2
18 neurotic disorder 10.2 FCGR3A IFNG IL10
19 diabetic angiopathy 10.2 CD40LG IL10
20 tungiasis 10.2 IFNG IL10
21 chondrodysplasia punctata, tibia-metacarpal type 10.2 CD40LG IFNA2
22 esophageal candidiasis 10.2 IFNA2 IFNG IL10
23 uterine ligament clear cell adenocarcinoma 10.1 IFNG IL10 TRPV1
24 lupus erythematosus 10.1
25 severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive 10.1 IFNG IL10 IL2
26 plantar wart 10.1 IFNG IL10 IL2
27 cyclosporiasis 10.1 IFNG IL10 IL2
28 chronic thromboembolic pulmonary hypertension 10.1 IFNG IL10 IL2
29 mental retardation, autosomal dominant 19 10.1 CD40LG IFNA2
30 acute myeloid leukemia with recurrent genetic anomaly 10.1 IFNG IL10 IL2
31 microcephaly 10.1 IFNG IL10 IL2
32 israeli tick typhus 10.1 CD40LG IFNG
33 abnormal retinal correspondence 10.1 IFNG IL10 IL2
34 rheumatoid arthritis 10.1
35 arthritis 10.1
36 causalgia 10.1 IFNG IL10 IL2
37 mansonelliasis 10.1 IFNG IL10 IL2
38 osteoarthritis 10.1 DPYD FCGR3A IFNA2
39 dengue hemorrhagic fever 10.1 IFNG IL10 IL2
40 facial nerve neoplasm 10.1 CD40LG COL17A1
41 liver inflammatory pseudotumor 10.1 IFNG IL10 IL2
42 blue toe syndrome 10.1 IFNG IL10 IL2
43 hemiplegia 10.1
44 retinitis 10.1
45 prostatic urethral cancer 10.1 IFNG IL10 IL2
46 pigmentation disease 10.1 IFNG IL10 IL2
47 type 2 papillary adenoma of the kidney 10.1 CD40LG FCGR3A IL10
48 periarthritis 10.1 IFNG IL10 IL2
49 spastic ataxia 7, autosomal dominant 10.1 CD40LG COL17A1
50 chickenpox 10.1

Graphical network of the top 20 diseases related to Herpes Zoster:



Diseases related to Herpes Zoster

Symptoms & Phenotypes for Herpes Zoster

Symptoms:

12
  • rash which is followed by blisters
  • headache
  • fever
  • malaise
  • itching
  • burning pain
  • paresthesia

UMLS symptoms related to Herpes Zoster:


angina pectoris, back pain, exanthema, fever, headache, pain, pruritus, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, equilibration disorder, sleeplessness

Drugs & Therapeutics for Herpes Zoster

Drugs for Herpes Zoster (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 371)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Capsaicin Approved Phase 4,Phase 3,Phase 2 404-86-4 1548943
2
Prednisolone Approved, Vet_approved Phase 4,Phase 2 50-24-8 5755
3
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
4
Foscarnet Approved Phase 4 63585-09-1, 4428-95-9 3415
5
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
6
Nepafenac Approved Phase 4 78281-72-8 151075
7
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2 83-43-2 6741
8
Ethanol Approved Phase 4 64-17-5 702
9
Methotrexate Approved Phase 4,Phase 3,Phase 2 1959-05-2, 59-05-2 126941
10
Adalimumab Approved Phase 4 331731-18-1 16219006
11
Budesonide Approved Phase 4 51333-22-3 63006 5281004
12
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2 148553-50-8 5486971
13
Tofacitinib Approved, Investigational Phase 4,Phase 2 477600-75-2
14
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2 58-05-9 54575, 6560146 143
15
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 59-30-3 6037
16
Phosphonoacetic Acid Experimental Phase 4 4408-78-0 546
17 Acyclovir Phase 4,Phase 3,Phase 2,Phase 1
18 valacyclovir Phase 4,Phase 3,Phase 2,Phase 1
19 Prednisolone acetate Phase 4,Phase 2
20 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
21 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
22 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
23 Neuroprotective Agents Phase 4,Phase 2
24 Neurotransmitter Agents Phase 4,Phase 3,Phase 2
25 Cyclooxygenase 2 Inhibitors Phase 4
26 Cyclooxygenase Inhibitors Phase 4,Phase 1
27 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2
28 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1
29 Dermatologic Agents Phase 4,Phase 3,Phase 2
30 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
31 Hormones Phase 4,Phase 3,Phase 2,Phase 1
32 Vaccines Phase 4,Phase 2,Phase 3,Phase 1
33 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
35 Prednisolone hemisuccinate Phase 4,Phase 2
36 Prednisolone phosphate Phase 4,Phase 2
37 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
38 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
39 Protective Agents Phase 4,Phase 3,Phase 2
40 Antiemetics Phase 4,Phase 2,Phase 1
41 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
42 Ketorolac Tromethamine Phase 4
43 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 1
44 Antimetabolites Phase 4,Phase 3,Phase 2
45 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1
46 Reverse Transcriptase Inhibitors Phase 4,Phase 3,Phase 2
47 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2
48 Methylprednisolone acetate Phase 4,Phase 2
49 Methylprednisolone Hemisuccinate Phase 4,Phase 2
50 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 444)
id Name Status NCT ID Phase
1 Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster Unknown status NCT02151240 Phase 4
2 Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine Unknown status NCT02146469 Phase 4
3 The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination Unknown status NCT01866566 Phase 4
4 Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation Unknown status NCT00940940 Phase 4
5 Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies Unknown status NCT00865540 Phase 4
6 Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain Unknown status NCT01264237 Phase 4
7 Qutenza for Critical Ischaemia in End Stage Renal Failure Unknown status NCT01704339 Phase 4
8 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4
9 T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020 Completed NCT01911065 Phase 4
10 Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine Completed NCT02173899 Phase 4
11 Safety of a Second Dose of Biken's Varicella Vaccine Completed NCT00830648 Phase 4
12 A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster Completed NCT02152800 Phase 4
13 ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034) Completed NCT01556451 Phase 4
14 Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin Completed NCT01684072 Phase 4
15 Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine Completed NCT01817270 Phase 4
16 Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine Completed NCT01815073 Phase 4
17 Varicella Vaccination With Pulmicort Completed NCT00641446 Phase 4
18 The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children Completed NCT01138215 Phase 4
19 ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020) Completed NCT00550745 Phase 4
20 Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™ Completed NCT02958345 Phase 4
21 Zostavax® at Minimum Release Specification Approaching Expiry Completed NCT00681031 Phase 4
22 Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis Completed NCT01356004 Phase 4
23 MMR and Varicella Vaccine in Premature Infants Completed NCT00156559 Phase 4
24 Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) Completed NCT00312858 Phase 4
25 Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00126997 Phase 4
26 Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) Completed NCT00326183 Phase 4
27 Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza Completed NCT01693380 Phase 4
28 Palatability Testing of a New Paediatric Formulation of Valacyclovir Completed NCT01682109 Phase 4
29 Safety Study of a Refrigerator-stable Formulation of VARIVAX® Completed NCT00432731 Phase 4
30 An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate Completed NCT02187055 Phase 4
31 MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine Completed NCT02225327 Phase 4
32 Pregabalin in the Treatment of Essential Tremor Completed NCT00646451 Phase 4
33 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Completed NCT02215863 Phase 4
34 Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV Completed NCT00329251 Phase 4
35 Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) Completed NCT00760747 Phase 4
36 Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients Recruiting NCT03016884 Phase 4
37 Acupuncture in Herpes Zoster Neuralgia (ACUZoster) Recruiting NCT00885586 Phase 4
38 Immune Response to Shingles Vaccination Recruiting NCT02624375 Phase 4
39 Safety and Immunogenicity of a Zoster Vaccine in SLE Recruiting NCT02477150 Phase 4
40 "Equistasi" and Gait in Hemiparesis Recruiting NCT02714478 Phase 4
41 Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine Active, not recruiting NCT02514018 Phase 4
42 Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children Active, not recruiting NCT01982409 Phase 4
43 The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination Enrolling by invitation NCT01830283 Phase 4
44 Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox Enrolling by invitation NCT02383797 Phase 4
45 Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine Not yet recruiting NCT02026089 Phase 4
46 Zoster Eye Disease Study Not yet recruiting NCT03134196 Phase 4
47 ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors Not yet recruiting NCT02444936 Phase 4
48 Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy Terminated NCT02408159 Phase 4
49 Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines Terminated NCT00138255 Phase 4
50 Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery Unknown status NCT00926419 Phase 2, Phase 3

Search NIH Clinical Center for Herpes Zoster

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: herpes zoster

Genetic Tests for Herpes Zoster

Anatomical Context for Herpes Zoster

MalaCards organs/tissues related to Herpes Zoster:

39
Skin, Eye, T Cells, Kidney, Colon, Testes, Bone

The Foundational Model of Anatomy Ontology organs/tissues related to Herpes Zoster:

18
Nerve Fiber

Publications for Herpes Zoster

Articles related to Herpes Zoster:

(show top 50) (show all 1230)
id Title Authors Year
1
Successful Treatment of Brachial Plexopathy Due to Herpes Zoster Infection With Intravenous Immunoglobulin. ( 27879550 )
2017
2
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. ( 28086817 )
2017
3
Gentiana scabra Bunge. Formula for Herpes Zoster: Biological Actions of Key Herbs and Systematic Review of Efficacy and Safety. ( 28078812 )
2017
4
Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project. ( 28042124 )
2017
5
Localized hypohidrosis is an unrecognized sequela of herpes zoster. ( 27986141 )
2017
6
Association of cigarette smoking with a past history and incidence of herpes zoster in the general Japanese population: the SHEZ Study. ( 28091339 )
2017
7
Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults a8Y50A years of age with a prior history of herpes zoster: a phase III, non-randomized, open-label clinical trial. ( 28068212 )
2017
8
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. ( 28057661 )
2017
9
Clinical characteristics of headache or facial pain prior to the development of acute herpes zoster of the head. ( 27978460 )
2017
10
Three cases of herpes zoster radiculitis in MS patients treated with natalizumab. ( 27645358 )
2016
11
A Rare Patient With Orbital Apex Syndrome, Anterior Uveitis, and Necrotizing Scleritis Due to Herpes Zoster Ophthalmicus. ( 28005810 )
2016
12
Herpes zoster in children. ( 27622252 )
2016
13
Acute Orbital Syndrome in Herpes Zoster Ophthalmicus: Clinical Features of 7 Cases. ( 27046033 )
2016
14
Concurrent hyphema and orbital apex syndrome following herpes zoster ophthalmicus in a middle aged lady. ( 28061417 )
2016
15
Shingles (Herpes Zoster) Vaccine (Zostavax(Ar)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia. ( 27189459 )
2016
16
Atypical pityriasis rosea presenting with a herald patch lesion on the healed site of herpes zoster: Wolf's isotopic response. ( 26678150 )
2016
17
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. ( 27626517 )
2016
18
Herpes Zoster Ophthalmicus: A Review for the Internist. ( 27644149 )
2016
19
Comorbidities: Stroke risk increased after herpes zoster infection. ( 27652501 )
2016
20
Prevention: Time to re-evaluate herpes zoster vaccination? ( 27052483 )
2016
21
Effect of Repetitive Intracutaneous Injections with Local Anesthetics and Steroids for Acute Thoracic Herpes Zoster and Incidence of Postherpetic Neuralgia. ( 27492741 )
2016
22
Herpes zoster reactivation after extracorporeal shock wave lithotripsy: A case report. ( 27555686 )
2016
23
Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010. ( 27622686 )
2016
24
Risk of Herpes Zoster and Family History: A Meta-analysis of Case-control Studies. ( 27057014 )
2016
25
Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis. ( 27387135 )
2016
26
A rare case report and appraisal of the literature on spontaneous tooth exfoliation associated with trigeminal herpes zoster. ( 27154513 )
2016
27
Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease. ( 27092286 )
2016
28
Favorable Long-term Prognosis of Cataract Surgery in Herpes Zoster Ophthalmicus. ( 27413505 )
2016
29
Incidence of serum antibody titers against varicella zoster virus in Japanese patients with herpes zoster. ( 28012212 )
2016
30
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. ( 27841441 )
2016
31
Herpes Zoster Masquerading as a Chemical Burn Secondary to Hair Dye. ( 27606555 )
2016
32
European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. ( 27579792 )
2016
33
Corneal Reinnervation and Sensation Recovery in Patients With Herpes Zoster Ophthalmicus: An In Vivo and Ex Vivo Study of Corneal Nerves. ( 26989956 )
2016
34
Transient Receptor Potential Vanilloid-1 in Epidermal Keratinocytes May Contribute to Acute Pain in Herpes Zoster. ( 26390894 )
2016
35
Herpes zoster occurring on scars: two cases. ( 27086602 )
2016
36
Disease Burden Due to Herpes Zoster among Population Aged a8Y50 Years Old in China: A Community Based Retrospective Survey. ( 27055179 )
2016
37
Herpes Zoster and the Risk for Stroke in Patients with Autoimmune Diseases. ( 27588578 )
2016
38
A case of miller fisher syndrome associated with preceding herpes zoster ophthalmicus. ( 27875624 )
2016
39
Association of Herpes Zoster and Type 1 Diabetes Mellitus. ( 27171477 )
2016
40
Orbital myositis: A rare complication of ophthalmic herpes zoster. ( 27595510 )
2016
41
Herpes Zoster Meningitis Presenting With a Cerebrospinal Fluid Leukemoid Reaction in an Adolescent With preB-ALL in Remission. ( 27322719 )
2016
42
Post Herpes Zoster Trigeminal Trophic Syndrome in a Child: An Example of Immunocompromised District. ( 26955150 )
2016
43
Case of thymoma-associated multi-organ autoimmunity following herpes zoster. ( 27943470 )
2016
44
COST-EFFECTIVENESS ANALYSIS OF HERPES ZOSTER VACCINATION IN ITALIAN ELDERLY PERSONS. ( 27624398 )
2016
45
The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling. ( 26994062 )
2016
46
Post-Herpes zoster myelitis in a very old patient: A complication not to be missed. ( 27440114 )
2016
47
Prevalence of Ocular Manifestations and Visual Outcomes in Patients With Herpes Zoster Ophthalmicus. ( 27741018 )
2016
48
Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster. ( 27193610 )
2016
49
Herpes Zoster as the Presenting Manifestation of Systemic Lupus Erythematosus (SLE): A Rare Case Report. ( 27134921 )
2016
50
Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. ( 27161774 )
2016

Variations for Herpes Zoster

Expression for Herpes Zoster

Search GEO for disease gene expression data for Herpes Zoster.

Pathways for Herpes Zoster

Pathways related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 28)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.22 CD40LG HLA-A IFNA2 IFNG IL10 IL2
2
Show member pathways
12.49 CD40LG IFNG IL10 IL2
3 12.4 CD40LG CD8A IFNG IL10 IL2
4
Show member pathways
12.37 FCGR3A HLA-A IFNA2 IFNG IL2
5
Show member pathways
12.24 CD40LG CD8A IFNG IL10 IL2
6
Show member pathways
12.24 CD40LG CD8A HLA-A IFNA2 IFNG IL10
7
Show member pathways
12.17 CD40LG FCGR3A IFNG IL10
8 12.14 FCGR3A IFNA2 IFNG IL10
9
Show member pathways
12.11 IFNA2 IFNG IL10 IL2
10 11.98 CD40LG CD8A HLA-A
11 11.97 CD40LG CD8A FCGR3A HLA-A
12
Show member pathways
11.86 HLA-A IFNA2 IFNG IL10 IL2
13
Show member pathways
11.83 IFNG IL10 IL2
14
Show member pathways
11.81 CD8A HLA-A IFNG IL2
15
Show member pathways
11.67 CD40LG IFNG IL2
16 11.63 CD40LG FCGR3A IL10
17 11.62 CD8A IFNA2 IFNG IL10 IL2
18 11.61 CD8A IFNG IL10 IL2
19
Show member pathways
11.58 CD40LG IFNG IL2
20 11.5 IFNA2 IFNG IL10 IL2
21 11.46 CD40LG IFNG IL10
22 11.42 IFNG IL10 IL2
23
Show member pathways
11.41 CD8A HLA-A IFNG IL2
24
Show member pathways
11.34 IFNG IL10 IL2
25 11.24 CD40LG IFNG IL2
26 11.18 IFNG IL10 IL2
27 11.07 IFNG IL10 IL2
28 10.9 CD8A IFNA2 IFNG IL10 IL2

GO Terms for Herpes Zoster

Cellular components related to Herpes Zoster according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 9.02 CD40LG CD8A FCGR3A IFNG TRPV1

Biological processes related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 16)
id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.83 CD40LG IFNA2 IL10 TRPV1
2 cell surface receptor signaling pathway GO:0007166 9.78 CD8A IFNA2 IFNG TRPV1
3 B cell differentiation GO:0030183 9.61 CD40LG IFNA2 IL10
4 positive regulation of T cell proliferation GO:0042102 9.58 CD40LG IFNG IL2
5 positive regulation of interleukin-12 production GO:0032735 9.56 CD40LG IFNG
6 positive regulation of peptidyl-serine phosphorylation of STAT protein GO:0033141 9.55 IFNA2 IFNG
7 defense response to protozoan GO:0042832 9.54 IFNG IL10
8 antigen processing and presentation GO:0019882 9.54 CD8A HLA-A IFNG
9 negative regulation of growth of symbiont in host GO:0044130 9.51 IFNG IL10
10 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.5 IFNA2 IFNG IL2
11 immune response GO:0006955 9.5 CD40LG CD8A FCGR3A HLA-A IFNG IL10
12 positive regulation of isotype switching to IgG isotypes GO:0048304 9.49 IFNG IL2
13 positive regulation of MHC class II biosynthetic process GO:0045348 9.46 IFNG IL10
14 B cell proliferation GO:0042100 9.33 CD40LG IFNA2 IL10
15 sensory perception of mechanical stimulus GO:0050954 9.26 IFNG TRPV1
16 regulation of immune response GO:0050776 9.1 CD40LG CD8A COL17A1 FCGR3A HLA-A IFNG

Molecular functions related to Herpes Zoster according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.02 CD40LG IFNA2 IFNG IL10 IL2

Sources for Herpes Zoster

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....